SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 309 filers reported holding SALIX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $4,435,000 | -86.0% | 25,665 | -90.7% | 0.13% | -39.9% |
| Q4 2014 | $31,775,000 | +31.2% | 276,452 | +78.3% | 0.22% | +18.0% |
| Q3 2014 | $24,220,000 | -23.9% | 155,020 | -39.9% | 0.19% | -23.5% |
| Q2 2014 | $31,831,000 | +88.8% | 258,052 | +58.6% | 0.25% | +81.6% |
| Q1 2014 | $16,858,000 | +42.8% | 162,705 | +24.0% | 0.14% | +41.7% |
| Q4 2013 | $11,804,000 | +83.6% | 131,246 | +36.6% | 0.10% | +31.5% |
| Q3 2013 | $6,428,000 | +404.9% | 96,110 | +399.3% | 0.07% | +421.4% |
| Q2 2013 | $1,273,000 | – | 19,250 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Verition Fund Management LLC | 2,787,800 | $481,760,000 | 55.98% |
| Brenner West Capital Advisors | 1,800,000 | $311,058,000 | 28.01% |
| FNY Managed Accounts LLC | 180,357 | $31,167,493,000 | 25.70% |
| Twin Securities, Inc. | 1,189,192 | $205,505,000 | 24.16% |
| FIRST NEW YORK SECURITIES LLC /NY | 98,099 | $16,952,488,000 | 16.70% |
| HARVEST MANAGEMENT LLC | 77,500 | $13,393,000 | 14.40% |
| Tyrus Capital S.A.M. | 687,800 | $118,859,000 | 13.24% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 472,550 | $81,661,000 | 11.65% |
| ARGENTIERE CAPITAL AG | 151,500 | $26,181,000 | 10.81% |
| Sachem Head Capital | 725,000 | $125,425,000 | 8.31% |